Felix Baker, 10% Owner at Entrada Therapeutics, Inc. (TRDA), bought 55,335 shares at $9.07 ($502K) on 2025-11-20, disclosed to the SEC on 2025-11-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.07 | 1,186 | $11K | 2.1% |
| 2 | $9.07 | 1,213 | $11K | 2.2% |
| 3 | $9.07 | 13,082 | $119K | 23.6% |
| 4 | $9.07 | 13,082 | $119K | 23.6% |
| 5 | $9.07 | 13,386 | $121K | 24.2% |
| 6 | $9.07 | 13,386 |
| $121K |
| 24.2% |
| Total | $9.07 avg | 55,335 | $502K | 100% |
| Filing → |
| KALA | BUY | 2024-12-31 | $4.0M | — | Filing → |
| MDGL | BUY | 2023-11-15 | $31.4M | — | Filing → |
| KOD | BUY | 2022-05-27 | $4.3M | — | Filing → |